{
  "id": 3775282,
  "title": "New data could widen use of AstraZeneca, Amgen immune disease drug",
  "url": "https://urgent.news/2026/08/27/new-data-could-widen-use-of-astrazeneca-amgen-immune-disease-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T15:58:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/astrazeneca-amgen-tezpire-eosinophilic-esophagitis-results/828946/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Tezspire succeeded in a study in eosinophilic esophagitis, which could become the drug’s third approved indication and unlock what’s viewed as a blockbuster opportunity.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "SCMP Business",
        "title": "China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial",
        "url": "https://urgent.news/2026/08/27/chinas-akeso-says-cancer-drug-beat-astrazenecas-imfinzi-in-phase-3",
        "published": "2026-08-27T02:07:51.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}